Anest. intenziv. Med. 2018;29(4):207-216
A new definition of status epilepticus and its pharmacological managementReview Article
- 1 I. neurologická klinika, Lékařská fakulta, Masarykova univerzita, Fakultní nemocnice u sv. Anny
- 2 Anesteziologicko-resuscitační klinika, Lékařská fakulta Masarykovy univerzity, Fakultní nemocnice u sv. Anny
Status epilepticus is a life-threatening condition with a high mortality rate, requiring urgent therapy. To unify the views on this topic, a new definition has been proposed that reflects the patho-physiology better than the previous one. The new definition particularly highlights time as a major factor in the evolution of status epilepticus and points to the possibility of irreversible changes in the brain caused by the ongoing epileptic activity. The choice of a suitable drug is essential in treating status epilepticus. In addition to the traditional drugs (phenytoin, valproate), new drugs which promise significant benefits are emerging (levetiracetam, lacosamide). Some rescue treatment options (e.g. ketamine) are also mentioned. The choice of appropriately aggressive therapy is important. It is a common mistake to use one treatment guideline for all types of status epilepticus even though it does not fit the clinical picture and can even aggravate the patient's condition. Non-convulsive status epilepticus in particular requires a different approach.
Keywords: status epilepticus; definition; classification; therapy; antiepileptic drugs
Received: May 2, 2018; Accepted: July 6, 2018; Published: August 1, 2018 Show citation
References
- Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus-Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56:1515-1523.
Go to original source...
Go to PubMed...
- Walton NY. Systemic effects of generalized convulsive status epilepticus. Epilepsia.1993;34:S54-S58.
Go to original source...
Go to PubMed...
- Treiman DM, DeGiorgio CM, Salisbury S, et al. Subtle generalized convulsive status epilepticus. Epilepsia. 1984;25:653.
- Dham BS, Hunter K, Rincon F. The epidemiology of status epilepticus in the United States. Neurocrit Care. 2014;20:476-483.
Go to original source...
Go to PubMed...
- DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996;46:1029-1035.
Go to original source...
Go to PubMed...
- Laccheo I, Sonmezturk H, Bhatt AB, et al. Non-convulsive status epileptici and non-convulsive seizures in neurological ICU patients. Neurocrit Care. 2015;22:202-211.
Go to original source...
Go to PubMed...
- Holtkamp M, Othman J, Buchheim K, Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry. 2005;76:534-539.
Go to original source...
Go to PubMed...
- Kantanen AM, Reinikainen M, Parviainen I, et al. Incidence and mortality of super-refractory status epilepticus in adults. Epilepsy Behav. 2015;49:131-134.
Go to original source...
Go to PubMed...
- DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol. 1995;12:316-325.
Go to original source...
- Shorvon SD, Ferlisi M. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain. 2012;135:2314-2328.
Go to original source...
Go to PubMed...
- Lowenstein DH, Bleck T, Macdonald RL. It's time to revise the definition of status epilepticus. Epilepsia. 1999;40:120-122.
Go to original source...
Go to PubMed...
- Mazarati AM, Baldwin RA, Sankar R, Wasterlain CG. Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res. 1998;814:179-185.
Go to original source...
Go to PubMed...
- Alvarez V, Lee JW, Drislane FW, et al. Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison. Epilepsia. 2015;56:1275-1285.
Go to original source...
Go to PubMed...
- Kolektiv autorů. Soubor minimálních diagnostických a terapeutických standardů u pacientů s epilepsií EpiStop 2017 [Internet]. Dostupné z http://www.clpe.cz/Epistandardy_2017_web.pdf
- Talukdar B, Chakrabarty B. Efficacy of buccal midazolam comparedto intravenous diazepam in controlling convulsions in children: Arandomized controlled trial. Brain Dev. 2009;31:744-749.
Go to original source...
Go to PubMed...
- Silbergleit R, Durkalski V, Lowenstein D, et al. NETT Investigators. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012;366:591-600.
Go to original source...
Go to PubMed...
- Mohamed, W., Mahulikar, A., Rao, S., et al. Inadequacy of Benzodiazepine dosing in Status Epilepticus patients admitted to Neurointensive Care Unit (P4. 223). Neurology. 2017;88:P4-223.
Go to original source...
- Perucca E, Hebdige S, Frigo GM, et al. Interaction between phenytoin and valproic acid: plasma protein binding and metabolit effects. Clin Pharmacol Ther. 1980;28:779-789.
Go to original source...
Go to PubMed...
- De Jong MJ, Karch AM, Lippincott's Critical Care Drug Guide. 1st edition. Philadelphia: Lippincott Williams & Wilkins, 2000.
- Johannessen SI, Landmark CJ. Antiepileptic Drug Interactions - Principles and Clinical Implications. Current Neuropharmacology. 2010;8:254-267.
Go to original source...
Go to PubMed...
- Annagur BB, Sayin AA, Akbaba N, Selvi Y. Valproic acid induced hyperammonemic encephalopathy: report of one case. In European Psychiatry. 2013;28:1.
Go to original source...
- Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs. 2002;16:695-714.
Go to original source...
Go to PubMed...
- Yoon HW, Giraldo EA, Wijdicks EF. Valproic acid and warfarin: an underrecognized drug interaction. Neurocrit Care. 2011;15:182-185.
Go to original source...
Go to PubMed...
- Trinka E, Dobesberger J. New treatment options in status epilepticus: a critical review on levetiracetam. Ther Adv Neurol Dis. 2009;2:79-91.
Go to original source...
Go to PubMed...
- Patsalos PN. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther. 2001;85:77-85.
Go to original source...
Go to PubMed...
- Zaccara G, Perucca P, Loiacono G, et al. The adverse event profile of lacosamide: a systematic review and meta-analysis of randomized controlled trials. Epilepsia. 2013;54:66-74.
Go to original source...
Go to PubMed...
- Cross SA, Curran MP. Lacosamide: in partial-onset seizures. Drugs. 2009;69:449-459.
Go to original source...
Go to PubMed...
- Yasiry Z, Shorvon SD. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies. Seizure. 2014;23:167-174.
Go to original source...
Go to PubMed...
- Bleck T, Cock H, Chamberlain J, et al. The established status epilepticus trial 2013. Epilepsia. 2013;54:89-92.
Go to original source...
Go to PubMed...
- Glauser T, Shinnar S, Gloss D, et al. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Currents. 2016;16:48-61.
Go to original source...
Go to PubMed...
- Young GB, Sharpe MD, Savard M, et al. Seizure detection with a commercially available bedside EEG monitor and the subhairline montage. Neurocrit Care. 2009;11:411-416.
Go to original source...
Go to PubMed...
- Haider HA, Esteller R, Hahn CD, et al. Sensitivity of quantitative EEG for seizure identification in the intensive care unit. Neurology. 2016;87:935-944.
Go to original source...
Go to PubMed...
- Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med. 1998;338:970-976.
Go to original source...
Go to PubMed...
- Betjemann JP, Lowenstein DH. Status epilepticus in adults. Lancet Neurol. 2015;14:615-624.
Go to original source...
Go to PubMed...
- Ferlisi M, Shorvon S. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recom-mendations for therapy. Brain. 2012;135:2314-2328.
Go to original source...
Go to PubMed...
- Yeoman P, Hutchinson A, Byrne A, et al. Etomidate infusions for the control of refractory status epilepticus. Intensive Care Med. 1989;15:255-259.
Go to original source...
Go to PubMed...
- Zeiler FA, Zeiler KJ, Teitelbaum J, et al. Modern inhalational anesthetics for refractory status epilepticus. Can J Neurol Sci. 2015;42:106-115.
Go to original source...
Go to PubMed...
- Synowiec AS, Yandora KA, Yenugadhati V, et al. The efficacy of topiramate in adult refractory status epilepticus: experience of a tertiary care center. Epilepsy Res. 2012;98:232-237.
Go to original source...
Go to PubMed...
- Sivakumar S, Ibrahim M, Parker D Jr, et al. Clobazam: An effective add-on therapy in refractory status epilepticus. Epilepsia. 2015;56:e83-e89.
Go to original source...
Go to PubMed...
- Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults: Still more questions than answers. Lancet neurology. 2011;10:922-930.
Go to original source...
Go to PubMed...
- Wijdicks EF, Rabinstein AA, Hocker SE, Fugate JE. Neurocritical Care.2nd edition. New York: Oxford university press, 2016.
Go to original source...
- Patsalos PN, Berry DJ, Bourgeois BF, et al. Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia. 2008;49:1239-1276.
Go to original source...
Go to PubMed...
- Jacob S, Nair AB. An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs. Drugs in R&D. 2016;16:303-316.
Go to original source...
Go to PubMed...
- Sutter R, Semmlack S, Kaplan PW. Nonconvulsive status epilepticus in adults - insights into the invisible. Nat Rev Neurol. 2016;12:281-293.
Go to original source...
Go to PubMed...
- Meierkord H, Holtkamp M. Non-convulsive status epilepticus in adults: clinical forms and treatment. Lancet Neurol. 2007;6:329-339.
Go to original source...
Go to PubMed...
- Marchi NA, Novy J, Faouzi M, et al. Status epilepticus: impact of therapeutic coma on outcome. Crit Care Med. 2015;43:1003-1009.
Go to original source...
Go to PubMed...
- Ferguson M, Bianchi MT, Sutter R, et al. Calculating the risk benefit equation for aggressive treatment of non-convulsive status epilepticus. Neurocrit Care. 2013;18:216-227.
Go to original source...
Go to PubMed...
- Rossetti AO, Oddo M, Logroscino G, Kaplan PW. Prognostication after cardiac arrest and hypothermia: a prospective study. Ann Neurol. 2010;67:301-307.
Go to original source...
Go to PubMed...